
    
      The primary objective of this study is to investigate whether treatment with EPI-743 has a
      discernible impact on visual function-including visual acuity, visual fields and color vision
      as well as on any of a number of functional and subject/clinician-rated scales relevant in
      the treatment of Friedreich's ataxia, and to determine the safety of treatment with EPI-743.
    
  